The Dose-Dependent Effect of RSR13, a Synthetic Allosteric Modifier of Hemoglobin, on Physiological Parameters and Brain Tissue Oxygenation in Rats

Advances in Experimental Medicine and Biology

Volumn 530, Issue , 2003, Pages 287-296

  Grinberg, Oleg Y ^a   Miyake, Minoru ^a   Hou, Huagang ^a   Steffen, Robert P ^b   Swartz, Harold M ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b Allos Therapeutics Inc   (United States)

Author keywords

Allosteric modifier; Cerebral pO2; EPR oximetry; RSR13

Indexed keywords

BIOLOGICAL RESPONSE MODIFIER; EFAPROXIRAL; HEMOGLOBIN;

ANIMAL TISSUE; BINDING AFFINITY; BLOOD GAS ANALYSIS; BRAIN ISCHEMIA; BRAIN OXYGEN TENSION; BRAIN TISSUE; CELL SUSPENSION; CONFERENCE PAPER; DRUG EFFECT; ELECTRON SPIN RESONANCE; NONHUMAN; OXYGEN AFFINITY; PRIORITY JOURNAL; PULSE OXIMETRY; RAT; TISSUE OXYGENATION;

ANIMALIA;

EID: 0242362072     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0075-9_27     Document Type: Conference Paper

References (13)

1. Randad RS, Mahran MA, Mehanna AS, and Abraham DJ.Allosteric modifiers of hemoglobin. 1. Design, synthesis, testing, and structure-allosteric activity relationship of novel hemoglobin oxygen affinity decreasing agents. J Med Chem 1991;34:752-757
2. Wireko FC, Glen E, Kellogg GE, and Abraham DJ. Allosteric modifiers of hemoglobin. 2. Crystallographically determined binding sites and hydrophobic binding/interaction. Analysis of novel hemoglobin oxygen effectors. J Med Chem 1991;34:758-767.
3. Abraham DJ, Wireko FC, and Randad RS. Allosteric modifiers of hemoglobin: 2-[4-[[(3,5-Disubstituted anilino) carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats Biochemistry 1992;31:9141-9149.
4. Kunert MP, Liard JF, and Abraham DJ. RSR-13, an allosteric effector of hemoglobin, increases systemic and iliac vascular resistance in rats. Am J Physiol 1996;271:H602-613.
5. Khandelwal SR, Randad RS, Lin PS, Meng H, Pittman RN, Kontos HA, Choi SC, Abraham DJ, and RupertSchmidt-Ullrich. Enhanced oxygenation in vivo by allosteric inhibitors of hemoglobin saturation. Am J. Physiol 1993;265:H1450-H1453.
6. Teicher BA, Ara G, Emi Y, et al. RSR:effects on tumor oxygenation and response to therapy. Drug Dev Res 1996;38:1-11.
7. Pagel PS, Hettrick DA, Montgomery MW, Kersten JR, Steffen RP and Warltier DC. RSR 13 , a synthetic modifier of hemoglobin-oxygen affinity, enhances the recovery of stunned myocardium in anesthetized dogs. J Pharmacology and Experimental Therapeutics 1998;2851-2858.
8. Jason A. Woods, Charles J. Storey, Evelyn E. Babcock and Craig R. Malloy.Right-shifting the oxyhemoglobin dissociation curve with rsr13:effects on high-energy phosphates and myocardial recovery after low-flow ischemia J Cardiovascular Pharmacology 1998;31:359-364.
9. Wei EP, Randad RS, Levasseur JE, Abraham DJ, and Kontos HA. Effect of local change in O2 saturation of hemoglobin on cerebral vasodilution from hypoxia and hypotension. Am J Physiol 1993;265:H1439-H1443.
10. Grocott HP, Bart RD, Sheng H, Miura Y, Steffen R, Pearlstein RD, and Warner DC. Effects of a synthetic allosteric modifier of hemoglobin oxygen affinity on outcome from global cerebral ischemia in the rat Stroke. 1998;29:1650-1655.
11. Swartz HM, Boyer S, Gast P, Glockner JF, Hu H, Liu KJ, Moussavi M, Norby SW, Walczak T, Vahidi N, Wu M, and Clarkson RB. Measurements of pertinent concentrations of oxygen in vivo. Magn Reson Med. 1991;20:333-339.
12. Swartz HM and Clarkson RB. The measurement of oxygen in vivo using EPR techniques. Phys Med Biol 1998;43:1957-1975.
13. Liu KJ, Gast P, Moussavi M, Norby SW, Vahidi N, Walczak T, Wu M, and Swartz HM. Lithium phthalocyanine:A probe for EPR oximetry in viable biological systems. Proc Natl Acad Sci 1993;90:5438-5442.